Evidence map›Paper›PMID 27319758›Full record

ArticleAllergy2017

Amoxicillin haptenates intracellular proteins that can be transported in exosomes to target cells.

F J Sánchez-Gómez, J M González-Morena, Y Vida, E Pérez-Inestrosa, M Blanca, M J Torres, D Pérez-Sala

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Allergy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Progress in study on the association between HLA genetic variation and adverse drug reactions.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2021
    Article
  3. Amoxicillin Haptenation ofFrontiers in pharmacology · 2021
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

F J Sánchez-GómezDepartment of Chemical and Physical Biology, Centro de Investigaciones Biológicas, CSIC, Madrid, Spain.
J M González-MorenaDepartment of Chemical and Physical Biology, Centro de Investigaciones Biológicas, CSIC, Madrid, Spain.
Y VidaDepartment of Organic Chemistry, University of Málaga, IBIMA, Málaga, Spain.
E Pérez-InestrosaDepartment of Organic Chemistry, University of Málaga, IBIMA, Málaga, Spain.
M BlancaAllergy Unit, IBIMA-Regional University Hospital of Málaga, UMA, Málaga, Spain.
M J TorresAllergy Unit, IBIMA-Regional University Hospital of Málaga, UMA, Málaga, Spain.
D Pérez-SalaDepartment of Chemical and Physical Biology, Centro de Investigaciones Biológicas, CSIC, Madrid, Spain.
Centro de Investigaciones Biológicas Margarita Salas · ESInstituto de Investigación Biomédica de Málaga · ESAndalusian Centre for Nanomedicine and Biotechnology · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAllergic reactions to β-lactams are among the most frequent causes of drug allergy and constitute an important clinical problem. Drug covalent binding to endogenous proteins (haptenation) is thought to be required for activation of the immune system. Nevertheless, neither the nature nor the role of the drug protein targets involved in this process is fully understood. Here, we aim to identify novel intracellular targets for haptenation by amoxicillin (AX) and their cellular fate.

methodsWe have treated B lymphocytes with either AX or a biotinylated analog (AX-B). The identification of protein targets for haptenation by AX has been approached by mass spectrometry and immunoaffinity techniques. In addition, intercellular communication mediated by the delivery of vesicles loaded with AX-B-protein adducts has been explored by microscopy techniques.

resultsWe have observed a complex pattern of AX-haptenated proteins. Several novel targets for haptenation by AX in B lymphocytes have been identified. AX-haptenated proteins were detected in cell lysates and extracellularly, either as soluble proteins or in lymphocyte-derived extracellular vesicles. Interestingly, exosomes from AX-B-treated cells showed a positive biotin signal in electron microscopy. Moreover, they were internalized by endothelial cells, thus supporting their involvement in intercellular transfer of haptenated proteins.

conclusionsThese results represent the first identification of AX-mediated haptenation of intracellular proteins. Moreover, they show that exosomes can constitute a novel vehicle for haptenated proteins, and raise the hypothesis that they could provide antigens for activation of the immune system during the allergic response.

Indexed as

Amoxicillinbeta-LactamsB-LymphocytesExosomesHaptensHumansProtein BindingProteinsProtein TransportProteomeProteomicsAmoxicillinbeta-LactamsHaptensProteinsProteomeamoxicillincellular protein targetsdrug adductsexosomeshaptenation

Identifiers

PMID27319758
OpenAlexW2436598274

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.